tiprankstipranks
Trending News
More News >
Lexaria Bioscience (LEXX)
NASDAQ:LEXX
US Market
Advertisement

Lexaria Bioscience (LEXX) Income Statement

Compare
236 Followers

Lexaria Bioscience Income Statement

Last quarter (Q3 2025), Lexaria Bioscience's total revenue was $174.00K, an increase of 107.14% from the same quarter last year. In Q3, Lexaria Bioscience's net income was $-3.79M. See Lexaria Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 25Dec 24Dec 23Dec 22
Total Revenue
$ 705.92K$ ―$ 464.28K$ 226.21K$ 255.40K
Gross Profit
$ 703.20K$ ―$ 459.46K$ 194.71K$ 183.56K
Operating Expenses
$ 12.58M$ ―$ 6.21M$ 6.73M$ 7.57M
Depreciation and Amortization
$ 0.00$ ―$ 76.15K$ 145.40K$ 102.72K
EBITDA
$ -11.88M$ ―$ -5.68M$ -6.39M$ -6.52M
Operating Income
$ -11.88M$ ―$ -5.75M$ -6.53M$ -6.62M
Other Income/Expenses
$ -21.10K$ ―$ -55.52K$ -178.50K$ -764.61K
Pretax Income
$ -11.90M$ ―$ -5.81M$ -6.71M$ -7.38M
Net Income
$ -11.90M$ ―$ -5.80M$ -6.66M$ -7.27M
Per Share Metrics
Basic EPS
$ -0.66$ ―$ -0.47$ -1.01$ -1.24
Diluted EPS
$ -0.66$ ―$ -0.47$ -1.01$ -1.24
Weighted Average Shares Outstanding
18.00M 12.38M 6.61M 5.89M
Weighted Average Shares Outstanding (Diluted)
18.00M 12.38M 6.61M 5.89M
Currency in USD

Lexaria Bioscience Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis